Credit Suisse’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Credit Suisse’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-9,000	Closed	-$567K	–	4191
2020 Q1	$567K	Hold	9,000	–	–	﹤0.01%	3037
2019 Q4	$1.11M	Sell	9,000 -11,000	-55%	-$985K	﹤0.01%	3045
2019 Q3	$1.33M	Buy	+20,000	New	+$1.34M	﹤0.01%	2797

Credit Suisse's ICPT Position: Q4 2023 in Review

Credit Suisse sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 69,928 shares — an estimated $1.3M sold.

Credit Suisse first reported a position in ICPT in Q4 2013 and held it in 40 quarters. The position peaked at $23.1M in Q3 2016. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Credit Suisse reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Credit Suisse sold 69,928 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $1.3M.
Credit Suisse first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2013 and held it in 40 quarters.
Credit Suisse's Intercept Pharmaceuticals, Inc. position peaked at $23.1M in Q3 2016.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.